arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

HCA Healthcare, Inc.

HCA

$413.27 ▲ +4.40 (+1.08%) at close

18 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

HCA Healthcare, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $97.7B

Dividend Yield 0.70%

Revenue Growth 7.1% ↘

Op. Margin —

ROIC —

FCF / Share $32.54 ↗

Trailing P/E 14.4x

Price / Book —

FCF Yield 7.9%

Debt / Equity -7.35

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$75.60B

↑ +7.1% —

Net Income Profit after all expenses

$6.78B

↑ +17.8% —

FCF / Share Free cash flow per share

$32.54

↑ +49.2% —

Long-Term Debt Long-term obligations

$44.28B

↑ +2.9% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability →

Returns ↑

Financial Health ↑

100

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$2.88 Latest / share

+9.1% YoY

+10.9% 8-yr CAGR

FY 2014

FY 2015

FY 2016

FY 2017

$1.40

FY 2018

$1.60

FY 2019

$0.43

FY 2020

$1.92

FY 2021

$2.24

FY 2022

$2.40

FY 2023

$2.64

FY 2024

$2.88

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	7.1% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-12%)	8.7% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8%)	7.9% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	2.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-68%)	14.0% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+75%)	0.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-95%)	10.0% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+25%)	7.0% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-12%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	15.7% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-0.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	93.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	8.1% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	-5.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	78.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-18.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	46.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	19.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	22.9% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-4.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-29.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	82.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	14.1% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	17.8% Good ↑ Good Improving Year-over-year change in net income	9.9% Fair ↓ Fair Declining Year-over-year change in net income	-7.1% Weak ↓ Weak Declining Year-over-year change in net income	-18.9% Weak ↓ Weak Declining Year-over-year change in net income	85.3% Excellent ↑ Excellent Improving Year-over-year change in net income	7.1% Fair ↓ Fair Declining Year-over-year change in net income	-7.4% Weak ↓ Weak Declining Year-over-year change in net income	70.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.3% Weak ↓ Weak Declining Year-over-year change in net income	35.7% Excellent ↑ Excellent Improving Year-over-year change in net income	13.5% Fair ↑ Fair Improving Year-over-year change in net income	20.5% Good ↓ Good Declining Year-over-year change in net income	-3.1% Weak ↓ Weak Declining Year-over-year change in net income	-34.9% Weak ↓ Weak Declining Year-over-year change in net income	104.2% Excellent Excellent Year-over-year change in net income	14.5% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	49.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	26.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	21.1% Good → Good Stable Year-over-year change in free cash flow	-14.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	-12.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	87.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	10.0% Fair Fair Year-over-year change in free cash flow	37.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	-25.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	11.1% Fair ↓ Fair Declining Year-over-year change in free cash flow	14.6% Fair Fair Year-over-year change in free cash flow	22.8% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	7.9% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	6.3% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	8.0% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	5.5% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	8.0% Fair Fair Compound annual revenue growth over 3 years	5.7% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	8.0% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	6.6% Fair → Fair Stable Compound annual revenue growth over 5 years	6.8% Fair Fair Compound annual revenue growth over 5 years	6.7% Fair Fair Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	13.9% Good ↓ Good Declining Compound annual EPS growth over 3 years	1.1% Caution ↓ Caution Declining Compound annual EPS growth over 3 years	20.1% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	23.7% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	25.5% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	22.0% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	10.9% Good ↓ Good Declining Compound annual EPS growth over 3 years	28.5% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	12.5% Good ↑ Good Improving Compound annual EPS growth over 3 years	29.1% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	12.1% Good ↑ Good Improving Compound annual EPS growth over 3 years	-6.0% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	7.3% Fair Fair Compound annual EPS growth over 3 years	13.7% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Effective Tax Rate (%) (%)	20.9% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.9% Fair → Fair Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.3% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.5% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.2% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.7% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	37.4% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	28.6% Caution ↓ Caution Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	31.9% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	31.8% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	9.0% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-25%)	8.2% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	8.1% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-33%)	9.4% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-22%)	11.8% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	7.3% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-39%)	6.8% Caution → Caution Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	8.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-32%)	5.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-58%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	10.2% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	8.0% Caution → Caution Stable Free cash flow as a percentage of revenue Optimal: > 10%	7.2% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.9% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	9.2% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	12.4% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.8% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	5.5% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.12x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.46x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.36x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Common Equity (%) (%)	-112.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-850%)	-230.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1637%)	-295.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2070%)	-203.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1460%)	—	—	-124.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-932%)	-76.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-610%)	-32.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-39.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-364%)	-28.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-287%)	-23.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-16.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-29.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	10.1% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	-7.35x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1325%)	-17.22x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2970%)	-22.32x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-3820%)	-13.76x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2394%)	-37.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-6277%)	54.20x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+8934%)	-12.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-2102%)	-6.63x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1205%)	-4.86x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-910%)	-4.30x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-816%)	-4.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-769%)	-3.73x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-721%)	-3.43x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-672%)	-2.99x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-599%)	-3.28x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-646%)	2.37x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+294%)	—	—
Net Debt (USD)	$43.24B	$41.10B	$38.66B	$37.18B	$33.13B	$29.21B	$33.10B	$32.32B	$32.33B	$30.73B	$29.75B	$28.86B	$27.96B	$28.23B	$26.68B	$27.81B	$-312.00M	$-465.00M

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$319.78	$273.02	$238.50	$207.45	$181.72	$152.34	$150.45	$134.40	$120.38	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$28.70	$22.27	$19.25	$19.43	$21.52	$11.10	$10.27	$10.90	$6.12	$7.53	$5.14	$4.30	$3.50	$3.65	$5.17	$2.83	$2.48	—
Free Cash Flow per Share (USD)	$32.54	$21.81	$17.21	$14.21	$16.65	$18.91	$10.09	$9.18	$6.65	—	—	—	$3.90	$5.25	$4.73	$4.13	$3.36	—
Dividend per Share (USD)	$2.88	$2.64	$2.40	$2.24	$1.92	$0.43	$1.60	$1.40	—	—	—	—	—	$6.50	—	—	—	—
Book Value per Share (USD)	$-26.83	$-10.00	$-6.68	$-9.98	$-3.05	$1.69	$-8.30	$-14.44	$-19.44	$-19.71	$-19.06	$-18.77	$-18.81	$-21.80	$-18.88	$27.90	—	—
Tangible Book Value per Share (USD)	$-26.83	$-10.00	$-6.68	$-9.98	$-3.05	$1.69	$-8.30	$-14.44	$-19.44	$-19.71	$-19.06	$-18.77	$-18.81	$-21.80	$-18.88	$27.90	—	—
Basic Weighted Avg Shares (shares)	236.41M	258.60M	272.40M	290.35M	323.31M	338.27M	341.21M	347.30M	362.31M	383.59M	414.19M	435.67M	445.07M	440.18M	476.61M	426.42M	425.57M	—
Dividend Payout Ratio (%)	10.0% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	11.9% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	12.5% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	11.5% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	8.9% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	3.9% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	15.6% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	12.8% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$-567.00M	$1.24B	$2.27B	$3.74B	$3.96B	$3.63B	$3.44B	$2.64B	$3.82B	$3.25B	$3.72B	$3.45B	$2.34B	$1.59B	$1.68B	$2.65B	—	—
LT Debt (USD)	$44.28B	$43.03B	$39.59B	$38.08B	$34.58B	$31.00B	$33.72B	$32.82B	$33.06B	$31.38B	$30.49B	$29.43B	$28.38B	$28.93B	$27.05B	$28.23B	—	—
Total Equity (USD)	$-6.03B	$-2.50B	$-1.77B	$-2.77B	$-933.00M	$572.00M	$-2.81B	$-4.95B	$-6.81B	$-7.30B	$-7.60B	$-7.89B	$-8.27B	$-9.66B	$-8.26B	$11.93B	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$75.60B	$70.60B	$64.97B	$60.23B	$58.75B	$51.53B	$51.34B	$46.68B	$43.61B	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$3.52B	$3.31B	$3.08B	$2.97B	$2.85B	$2.72B	$2.60B	$2.28B	$2.13B	$1.97B	$1.90B	$1.82B	$1.75B	$1.68B	$1.47B	$1.42B	$1.43B	—
Net Income, GAAP (USD)	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B	$3.75B	$3.50B	$3.79B	$2.22B	$2.89B	$2.13B	$1.88B	$1.56B	$1.60B	$2.46B	$1.21B	$1.05B	—
Operating Cash Flow (USD)	$12.64B	$10.51B	$9.43B	$8.52B	$8.96B	$9.23B	$7.60B	$6.76B	$5.43B	—	—	—	$3.68B	$4.17B	$3.93B	$3.08B	$2.75B	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

HCA Healthcare, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCA with peers